234 related articles for article (PubMed ID: 11385811)
1. Therapeutic equivalence of the Sofotec Novolizer to established standard devices in COPD and asthma.
Kunkel G; Chuchalin AG
Curr Opin Pulm Med; 2001 Apr; 7 Suppl 1():S15-7. PubMed ID: 11385811
[TBL] [Abstract][Full Text] [Related]
2. Novolizer: a multidose dry powder inhaler.
Fenton C; Keating GM; Plosker GL
Drugs; 2003; 63(22):2437-45; discussion 2447-8. PubMed ID: 14609355
[TBL] [Abstract][Full Text] [Related]
3. Stability and performance characteristics of a budesonide powder for inhalation with a novel dry powder inhaler device.
Fyrnys B; Stang N; Wolf-Heuss E
Curr Opin Pulm Med; 2001 Apr; 7 Suppl 1():S7-11. PubMed ID: 11385814
[TBL] [Abstract][Full Text] [Related]
4. The Novolizer: a multidose dry powder inhaler.
Siddiqui MA; Plosker GL
Treat Respir Med; 2005; 4(1):63-9. PubMed ID: 15725051
[TBL] [Abstract][Full Text] [Related]
5. Novolizer: how does it fit into inhalation therapy?
Magnussen H
Curr Med Res Opin; 2005; 21 Suppl 4():S39-46; discussion S47. PubMed ID: 16138944
[TBL] [Abstract][Full Text] [Related]
6. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD.
Brashier B; Dhembare P; Jantikar A; Mahadik P; Gokhale P; Gogtay JA; Salvi SS
Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763
[TBL] [Abstract][Full Text] [Related]
7. [Inhaler therapy for adults with obstructive lung diseases: powder or aerosol?].
Dekhuijzen PN
Ned Tijdschr Geneeskd; 1998 Jun; 142(24):1369-74. PubMed ID: 9752023
[TBL] [Abstract][Full Text] [Related]
8. Air classifier technology (ACT) in dry powder inhalation Part 4. Performance of air classifier technology in the Novolizer multi-dose dry powder inhaler.
de Boer AH; Hagedoorn P; Gjaltema D; Goede J; Frijlink HW
Int J Pharm; 2006 Mar; 310(1-2):81-9. PubMed ID: 16442246
[TBL] [Abstract][Full Text] [Related]
9. Clinical equivalence trial on budesonide delivered either by the Novolizer multidose dry powder inhaler or the Turbuhaler in asthmatic patients.
Chuchalin AG; Kremer HJ; Metzenauer P; O'Keefe E; Hermann R
Respiration; 2002; 69(6):502-8. PubMed ID: 12457002
[TBL] [Abstract][Full Text] [Related]
10. Inhalatory therapy training: a priority challenge for the physician.
Melani AS
Acta Biomed; 2007 Dec; 78(3):233-45. PubMed ID: 18330086
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of budesonide Clickhaler and Turbuhaler in adult asthma.
Morice A; Das S; Ellis S;
J Asthma; 2005 Oct; 42(8):697-703. PubMed ID: 16266962
[TBL] [Abstract][Full Text] [Related]
12. Clinical equivalence of budesonide dry powder inhaler and pressurized metered dose inhaler.
Srichana T; Juthong S; Thawithong E; Supaiboonpipat S; Soorapan S
Clin Respir J; 2016 Jan; 10(1):74-82. PubMed ID: 25043636
[TBL] [Abstract][Full Text] [Related]
13. Factors guiding the choice of delivery device for inhaled corticosteroids in the long-term management of stable asthma and COPD: focus on budesonide.
Thorsson L; Geller D
Respir Med; 2005 Jul; 99(7):836-49. PubMed ID: 15939245
[TBL] [Abstract][Full Text] [Related]
14. [Update on inhalation therapy in asthma and obstructive bronchopulmonary diseases].
Boulet LP; d'Amours P; Bérubé D; Rouleau M; Parent JG; Pelletier C; Touchette C
Union Med Can; 1994 Jan; 123(1):23-31. PubMed ID: 8109063
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of the bronchodilator effect of salbutamol between pressure metered dosed inhaler and dry powder inhaler in patients with stable bronchial asthma].
Yoshimi Y; Fujimura M; Yasui M; Kasahara K; Nakao S
Arerugi; 2004 May; 53(5):502-7. PubMed ID: 15247530
[TBL] [Abstract][Full Text] [Related]
16. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
Murphy K; Noonan M; Silkoff PE; Uryniak T
Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
[TBL] [Abstract][Full Text] [Related]
17. A single blinded randomised trial to compare the efficacy and safety of once daily budesonide (400microg) administered by turbuhaler with beclomethasone dipropionate (400microg) given twice daily through a metered-dose inhaler in patients with mild to moderate asthma.
Ige OM; Sogaolu OM
Afr J Med Med Sci; 2004 Jun; 33(2):155-60. PubMed ID: 15565935
[TBL] [Abstract][Full Text] [Related]
18. Comparative in vitro performance evaluation of the Novopulmon 200 Novolizer and Budesonid-ratiopharm Jethaler: two novel budesonide dry powder inhalers.
de Boer AH; Gjaltema D; Hagedoorn P; Frijlink HW
Pharmazie; 2004 Sep; 59(9):692-9. PubMed ID: 15497751
[TBL] [Abstract][Full Text] [Related]
19. Variability of fine particle dose and lung deposition of budesonide delivered through two multidose dry powder inhalers.
Munzel U; Marschall K; Fyrnys B; Wedel M
Curr Med Res Opin; 2005 Jun; 21(6):827-33. PubMed ID: 15969882
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of inhalation therapy in chronic obstructive pulmonary disease and asthma.
Pavia D
Respirology; 1997; 2 Suppl 1():S5-10. PubMed ID: 9400688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]